|
LIN54 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.950200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.051020E-01 |
| Normal-vs-Stage2 |
7.307800E-01 |
| Normal-vs-Stage3 |
2.623600E-01 |
| Normal-vs-Stage4 |
1.373590E-02 |
| Stage1-vs-Stage2 |
6.253400E-01 |
| Stage1-vs-Stage3 |
2.816400E-02 |
| Stage1-vs-Stage4 |
3.571800E-04 |
| Stage2-vs-Stage3 |
3.123800E-01 |
| Stage2-vs-Stage4 |
1.094360E-01 |
| Stage3-vs-Stage4 |
3.988200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.190800E-01 |
| Normal-vs-AfricanAmerican |
3.340000E-02 |
| Normal-vs-Asian |
6.695600E-01 |
| Caucasian-vs-AfricanAmerican |
1.279560E-02 |
| Caucasian-vs-Asian |
8.462600E-01 |
| AfricanAmerican-vs-Asian |
1.795440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.502800E-01 |
| Normal-vs-Female |
8.640800E-01 |
| Male-vs-Female |
8.997200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.679800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.852400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.891200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.857200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.058360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.828200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.617400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.472370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.123440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.380800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.278070E-02 |
| Normal-vs-Grade 2 |
1.632750E-01 |
| Normal-vs-Grade 3 |
7.260200E-01 |
| Normal-vs-Grade 4 |
3.975300E-04 |
| Grade 1-vs-Grade 2 |
2.451600E-01 |
| Grade 1-vs-Grade 3 |
2.169600E-02 |
| Grade 1-vs-Grade 4 |
5.419400E-04 |
| Grade 2-vs-Grade 3 |
1.049760E-01 |
| Grade 2-vs-Grade 4 |
5.84129999999794E-05 |
| Grade 3-vs-Grade 4 |
3.098100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.878260E-03 |
| Normal-vs-ccB subtype |
1.389380E-01 |
| ccA subtype-vs-ccB subtype |
9.681100000003E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.081000E-01 |
| Normal-vs-N1 |
3.321200E-01 |
| N0-vs-N1 |
4.173200E-01 |
|
|
